# US 2026/0208125 A1 · Process of manufacturing a device and device for the treatment of fluids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0208125 A1
- Document ID: US20260208125A1
- Status: Published application
- Kind: A1
- Application number: 19/138,275
- Filed: 2023-12-11
- Published: 2026-07-23
- Earliest claimed: 2022-12-12
- Assignees: Medica Corporation; Setlance S.R.L.
- Applicants: Medica S.P.A; Setlance S.R.L.
- Inventors: Letizia Bocchi; Giuseppe Palumbo; Alessandro Pini; Chiara Falciani; Luisa Bracci
- Web page: https://patentgrep.com/patent/US20260208125A1

## CPC

- B01D 69/144: {containing embedded or bound biomolecules}
- B01D 67/00931: {by introduction of specific groups after membrane formation, e.g. by grafting}
- B01D 69/08: Hollow fibre membranes (manufacture of hollow fibres D01D5/24, D01F1/08)
- B01D 71/68: Polysulfones; Polyethersulfones
- A61M 1/3679: {by absorption (A61M1/3675 takes precedence)}
- B01D 2221/10: Separation devices for use in medical, pharmaceutical or laboratory applications, e.g. separating amalgam from dental treatment residues
- B01D 2257/91: Bacteria; Microorganisms
- B01D 2257/93: Toxic compounds not provided for in groups B01D2257/00 - B01D2257/708
- B01D 2323/34: Use of radiation
- B01D 2323/36: Introduction of specific chemical groups
- B01D 2323/38: Graft polymerization
- B01D 2323/385: involving radiation
- B01D 2325/48: Antimicrobial properties
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Process of manufacturing a device (1) for the treatment of fluids, comprising a combination step, during which a substrate, comprising hollow fibre membranes, is combined with a compound having one or more peptides with sequence KKIRVRLSA (SEQ ID NO. 1) so that a chemical bond with one another is created; the hollow fibre membranes comprise: polysulfone, polyethersulfone, polysulfone with polyvinylpyrrolidone, polyethersulfone with polyvinylpyrrolidone and derivatives thereof; the device (1) is surprisingly capable of removing live bacteria and endotoxins from a biological fluid (e.g. blood plasma).

## Claims

### Claim 1

A process of manufacturing a device (1) for the treatment of fluids; the device (1) comprises treated hollow fiber membranes (7);
the process comprises:
a combination step, during which a substrate, comprising hollow fiber membranes, is combined with at least one compound having at least one peptide with sequence KKIRVRLSA (SEQ ID NO. 1) so that said at least one compound becomes covalently linked to the substrate and the treated hollow fiber membranes (7) are obtained;
the hollow fiber membranes comprising a base material chosen from the group consisting of: polyethersulfone, polyethersulfone with polyvinylpyrrolidone and derivatives thereof;
during the combination step, said substrate comes into contact with said compound so as to obtain a mixture of the substrate and of the compound; during the combination step, said mixture is treated with ionizing radiations so that the at least one compound becomes covalently linked to the hollow fiber membranes and the treated hollow fiber membranes are obtained (7);
each one of the amino acids of said peptide having, independently of the other ones, L or D configuration.

### Claim 2 (depends on 1)

The process according to claim 1, wherein, during the combination step, said mixture is treated with beta and/or gamma radiations.

### Claim 3 (depends on 2)

The process according to claim 2, wherein, during the combination step, said mixture is treated with an amount smaller than 50 KGy of the beta and/or gamma radiations.

### Claim 4 (depends on 2)

The process according to claim 2, wherein, during the combination step, the substrate and the compound come into contact with one another inside a cartridge; during the combination step, the cartridge containing said mixture is treated with the beta and/or gamma radiations.

### Claim 5 (depends on 1)

The process according to claim 1, wherein, during the combination step, a liquid containing said compound comes into contact with said substrate; in particular, the liquid is inserted into said cartridge, in which, more in particular, the substrate is located.

### Claim 6 (depends on 1)

The process according to claim 1, wherein the compound has at least two said peptides with sequence KKIRVRLSA (SEQ ID NO. 1).

### Claim 7 (depends on 1)

The process according to claim 1, wherein said compound has a formula chosen from the group consisting of (I) and (II):
wherein each R1 represents said peptide; X1, X2 and X3 are the same or different from one another and represent, each one independently of the other ones, an at least bifunctional radical (in particular, an amino acid); Y1 is chosen from —H, a further amino acid (in particular, -beta-alanine or -cysteine) and a further peptide;
wherein each R1 represents said peptide; X1, X2, X3, X4, X5, X6, X7, X8, X9 and X10 are the same or different from one another and represent, each one independently of the other ones, an at least bifunctional radical; Y1 is chosen from —H, a further amino acid and a further peptide.

### Claim 8 (depends on 1)

The process according to claim 1, wherein each one of the hollow fibre membranes has a side wall, comprising a base material, and an inner cavity, which is delimited by the side wall; the side wall has a thickness ranging from circa 25 μm to circa 150 μm as well as an outer surface provided with pores with a diameter ranging from circa 0.1 μm to circa 15 μm and an inner surface provided with pores with a diameter ranging from circa 5 nm to circa 200 nm; the inner cavity has a cross section with an area ranging from circa 5000 μm2 to circa 200000 μm2;
the hollow fiber membranes are granules with a length ranging from circa 0.1 mm to circa 50 mm.

### Claim 9 (depends on 1)

The process according to claim 1, wherein said compound has formula (III):

### Claim 10 (depends on 1)

The process according to claim 1, wherein during the combination step, said mixture is treated with beta radiations.

### Claim 11

A device for the treatment of fluids; the device (1) comprises treated hollow fiber membranes (7), which comprise a base material chosen from the group consisting of: polyethersulfone, polyethersulfone with polyvinylpyrrolidone and derivatives thereof;
the treated hollow fiber membranes (7) further comprise a compound having at least one peptide with sequence KKIRVRLSA (SEQ ID NO. 1) covalently linked to the base material;
each one of the amino acids of said peptide having, independently of the other ones, L or D configuration.

### Claim 12 (depends on 11)

The device according to claim 11 and comprising a cartridge provided with at least an inlet and an outlet and containing said treated hollow fiber membranes (7);
the treated hollow fiber membranes are granules with a length ranging from circa 0.1 mm to circa 50 mm;
the compound has at least two peptides with sequence KKIRVRLSA (SEQ ID NO. 1).

### Claim 13 (depends on 11)

The device according to claim 11, wherein said compound has a formula chosen from the group consisting of (I) and (II):
wherein each R1 represents said peptide; X1, X2 and X3 are the same or different from one another and represent, each one independently of the other ones, an at least bifunctional radical; Y1 is chosen from —H, a further amino acid and a further peptide; and
wherein each R1 represents said peptide; X1, X2, X3, X4, X5, X6, X7, X8, X9 and X10 are the same or different from one another and represent, each one independently of the other ones, an at least bifunctional radical; Y1 is chosen from —H, a further amino acid and a further peptide.

### Claim 14 (depends on 11)

The device according to claim 11, wherein each one of the hollow fiber membranes has a side wall, comprising a base material, and an inner cavity, which is delimited by the side wall; in particular, the side wall has a thickness ranging from circa 25 μm to circa 150 μm said compound has formula (III):

### Claim 15 (depends on 11)

A use of the device (1) of claim 11 for the at least partial removal of live bacteria and endotoxins from a fluid; the use provides for feeding the fluid through the device (1).

### Claim 16

Treated hollow fiber membranes; the treated hollow fiber membranes (7) comprise a base material chosen from the group consisting of: polyethersulfone, polyethersulfone with polyvinylpyrrolidone and derivatives thereof;
the treated hollow fibre membranes (7) further comprise a compound having at least one peptide with sequence KKIRVRLSA (SEQ ID NO. 1) covalently linked to the base material;
each one of the amino acids of said peptide having, independently of the other ones, L or D configuration.
